Cargando…

CGRP outflow into jugular blood and cerebrospinal fluid and permeance for CGRP of rat dura mater

BACKGROUND: Calcitonin gene-related peptide (CGRP) is released from activated meningeal afferent fibres in the cranial dura mater, which likely accompanies severe headache attacks. Increased CGRP levels have been observed in different extracellular fluid compartments during primary headaches such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Risch, Miriam, Vogler, Birgit, Dux, Mária, Messlinger, Karl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424805/ https://www.ncbi.nlm.nih.gov/pubmed/34496764 http://dx.doi.org/10.1186/s10194-021-01320-9

Ejemplares similares

The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow
por: Dux, Mária, et al.
Publicado: (2022)

Role Of Cgrp In Sensitization Of Dura Mater
por: Messlinger, K.
Publicado: (2001)

The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats
por: Vogler, Birgit, et al.
Publicado: (2023)

Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab
por: Benedicter, Nicola, et al.
Publicado: (2023)

CGRP measurements in human plasma – a methodological study
por: Messlinger, Karl, et al.
Publicado: (2021)

Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels
por: Kleeberg-Hartmann, Johanna, et al.
Publicado: (2021)

The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
por: Messlinger, Karl
Publicado: (2018)

The chicken and egg problem: CGRP release due to trigeminal activation or vice versa?
por: Messlinger, Karl
Publicado: (2021)

Sarcoma of the Dura Mater
por: Pal, S. B.
Publicado: (1916)

Tumour of the Dura Mater
por: Moinet, F.
Publicado: (1876)

Short Report of Longitudinal CGRP-Measurements in Migraineurs During a Hypoxic Challenge
por: Frank, Florian, et al.
Publicado: (2022)

CGRP and CGRP receptors in human and rhesus monkey cerebellum
por: Eftekhari, S, et al.
Publicado: (2013)

Case of Hæmatoma of the Dura Mater
por: Monro, T. K.
Publicado: (1896)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

Comparison of Biomechanical Properties of Dura Mater Substitutes and Cranial Human Dura Mater : An In Vitro Study
por: Kizmazoglu, Ceren, et al.
Publicado: (2019)

Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
por: Haanes, Kristian Agmund, et al.
Publicado: (2020)

Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate
por: Kageneck, Charlotte, et al.
Publicado: (2014)

Case of Fibrous Tumour of the Dura Mater
por: Lyell, John
Publicado: (1850)

Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo
por: Jamaluddin, Aqfan, et al.
Publicado: (2022)

Serotonin and CGRP in Migraine
por: Aggarwal, Milan, et al.
Publicado: (2012)

New CGRP Antagonists
por: Doods, H. N., et al.
Publicado: (2001)

Cgrp Characterization And Classification
por: Marshall, Ian
Publicado: (2001)

CGRP in Primary Headaches
por: Edvinsson, Lars
Publicado: (2001)

Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system
por: Eftekhari, S, et al.
Publicado: (2013)

The Role of Cgrp-Receptor Component Protein (Rcp) in Cgrp-Mediated Signal Transduction
por: Prado, M. A., et al.
Publicado: (2001)

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
por: Berman, Gary, et al.
Publicado: (2020)

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Cavernous hemangioma of the dura mater mimicking meningioma
por: Di Vitantonio, Hambra, et al.
Publicado: (2015)

On the Clinical History and Diagnosis of Hæmatoma of the Dura Mater
por: Finlayson, James
Publicado: (1882)

Case of Tumours in the Skull, Dura Mater, and Brain
por: Wishart, J. H.
Publicado: (1822)

Case of Peculiar Disease of the Skull and Dura Mater
por: Balfour, J. H.
Publicado: (1835)

Where Did the Dura Mater Come from?
por: Suh, Dae Chul
Publicado: (2020)

Role for TRPA1 receptor channels in trigeminal afferent activation and neuropeptide release from rat cranial dura mater
por: Albrecht, S, et al.
Publicado: (2013)

Characterization of transit rates in the large intestine of mice following treatment with a CGRP antibody, CGRP receptor antibody, and small molecule CGRP receptor antagonists
por: Johnson, Kirk W., et al.
Publicado: (2022)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

CGRP and the Trigeminal System in Migraine
por: Iyengar, Smriti, et al.
Publicado: (2019)

The CGRP-Antagonist BIBN4096BS Discriminates between the Action of α- and β-CGRP In Vitro
por: Wu, Dongmei, et al.
Publicado: (2001)

Effect of Xiongmatang Extract on Behavioral and TRPV1-CGRP/CGRP-R Pathway in Rats With Migraine
por: Liu, Dingding, et al.
Publicado: (2022)

Excitatory Effects of Calcitonin Gene-Related Peptide (CGRP) on Superficial Sp5C Neurons in Mouse Medullary Slices
por: Zheng, Fang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ig07t2q84qja6hj5hgkoe07atn